Vasomedical Inc. (VASO) Reports A Q3 Loss of $0.01
More News related to VASO
- Vasomedical Inc. (VASO) Announces Resignation of CFO, Company Names Tricia Efstathiou as Replacement
- Vasomedical (VASO) Anticipates Trading on Bulletin Board
- Vasomedical Inc. (VASO) Reports A Q3 Loss of $0.01
- Earnings Due Out After The Close Today & Before The Open Monday 04.17.06
- VASO Restructures to Focus on Congestive Heart Failure
More News related to Earnings
- Transocean (RIG) Promotes Saltiel to EVP and COO
- Travelzoo (TZOO) Names Chris Loughlin to CEO, Effective July 2010
- Sysco Corp. (SYY) Names Twila Day to SVP and CIO
- NexMed (NEXM) Names Bassam Damaj to CEO, Will Replace Liu - DJN
- UTEK (UTK) Names President Schaedler to CEO
Vasomedical Inc. (Nasdaq: VASO) reports a Q3 loss of $0.01 vs. loss of $0.03 for Q3 2005. Revenues were $2.8 million vs. $3.0 million for Q3 2005.
Vasomedical, Inc. is primarily engaged in designing, manufacturing, marketing and supporting EECP(R) external counterpulsation systems based on the Company's unique proprietary technology. EECP therapy is a noninvasive, outpatient therapy for the treatment of diseases of the cardiovascular system currently indicated for use in cases of stable or unstable angina, congestive heart failure, acute myocardial infarction and cardiogenic shock.
Related Categories
EarningsStocks Mentioned
-0.01Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
